Skip to content
Screener

Kura Oncology KURA Operating margin

Operating margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
26.5%+2.8pp
Amgen logo
AmgenAMGN
30%+6.5pp
Exelixis logo
ExelixisEXEL
39.9%+8.5pp
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-102.8%-47.8pp
AbbVie logo
AbbVieABBV
26.2%
Nuvation Bio logo
Nuvation BioNUVB
-81%-39.4pp

Other financials

Income statement

See full
Revenue$18.3M+29.5%
Gross profit$18.0M
Operating income-$78.8M-21.8%
Net income-$73.3M-27.7%
EPS (diluted)-$0.83-25.8%

Balance sheet

See full
Cash & equivalents$39.1M-23.8%
Total debt$24.3M+25.4%
Total equity$107.9M-70.4%
Total assets$652.6M-12.3%

Cash flow

See full
Operating cash flow-$85.9M-19.4%
CapEx$128.0K-56.2%
Free cash flow-$86.0M-19.1%

Valuation

See full
Market cap$849.57M+76.7%
Enterprise value$834.76M+99.5%
P/S11.9×+3.3×

Profitability

See full
Net margin-411.2%+125pp
FCF margin130.6%+74.1pp

Returns & leverage

See full
Return on equity-124.7%-252pp
Debt / equity0.2×+0.2×
Current ratio6.1×-1.9×

Where this comes from

Calculated from Kura Oncology’s reported figures.

Based on trailing twelve months.

The source filing: Kura Oncology’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219481

FAQ

What is Kura Oncology's operating margin?
Kura Oncology (KURA) reported operating margin of -443.5% in Q1 2026.
How has Kura Oncology's operating margin changed year-over-year?
Kura Oncology's operating margin decreased by 18.9% year-over-year, from -373.2% to -443.5%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Ask your AI about Kura Oncology's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude